Correlation Between CureVac NV and BioNTech
Can any of the company-specific risk be diversified away by investing in both CureVac NV and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CureVac NV and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CureVac NV and BioNTech SE, you can compare the effects of market volatilities on CureVac NV and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CureVac NV with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CureVac NV and BioNTech.
Diversification Opportunities for CureVac NV and BioNTech
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between CureVac and BioNTech is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding CureVac NV and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and CureVac NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CureVac NV are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of CureVac NV i.e., CureVac NV and BioNTech go up and down completely randomly.
Pair Corralation between CureVac NV and BioNTech
Assuming the 90 days horizon CureVac NV is expected to generate 1.39 times more return on investment than BioNTech. However, CureVac NV is 1.39 times more volatile than BioNTech SE. It trades about -0.05 of its potential returns per unit of risk. BioNTech SE is currently generating about -0.12 per unit of risk. If you would invest 330.00 in CureVac NV on December 31, 2024 and sell it today you would lose (53.00) from holding CureVac NV or give up 16.06% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
CureVac NV vs. BioNTech SE
Performance |
Timeline |
CureVac NV |
BioNTech SE |
CureVac NV and BioNTech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CureVac NV and BioNTech
The main advantage of trading using opposite CureVac NV and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CureVac NV position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.CureVac NV vs. BioNTech SE | CureVac NV vs. Moderna | CureVac NV vs. Nel ASA | CureVac NV vs. Ballard Power Systems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance |